B. Rossi

Pharmacological Enhancement of Mutated α-Glucosidase Activity in Fibroblasts from Patients with Pompe Disease.

A. Ballabio, G. Meroni, B. Bembi, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Abnormal mannose-6-phosphate receptor trafficking impairs recombinant alpha-glucosidase uptake in Pompe disease fibroblasts

G. Andria, G. Parenti, M. D. De Matteis, 2008, PathoGenetics.

The Pharmacological Chaperone N-butyldeoxynojirimycin Enhances Enzyme Replacement Therapy in Pompe Disease Fibroblasts

M. Barone, G. Andria, G. Parenti, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Clinical evaluation of a RT-LAMP SARS-CoV-2 test for the Point-Of-Care, rapid, low-cost, integrating sample solid phase extraction and on which reagents are lyophilized.

J. Olivo-Marin, P. Tabeling, J. Manuguerra, 2021, medRxiv.

Pharmacological enhancement of mutated alpha-glucosidase activity in fibroblasts from patients with Pompe disease.

A. Ballabio, G. Meroni, B. Bembi, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Evolutionary Dynamics of SARS-CoV-2 in Space and Time During the First Phase of the Epidemic in Italy

C. D. Vecchio, Luigi Ruggerone, E. Teti, 2021 .

AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease

Francesca Iacobellis, Andrea Ballabio, A. Ballabio, 2017, Scientific Reports.

A chaperone enhances blood α-glucosidase activity in Pompe disease patients treated with enzyme replacement therapy.

Carmine Mollica, Anna Pichiecchio, Simona Fecarotta, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

The pharmacological chaperone 1‐deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha‐glucosidase

D. Lockhart, J. Flanagan, M. Cubellis, 2009, Human mutation.

AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease

A. Ballabio, R. Polishchuk, G. Diez-Roux, 2017, Scientific Reports.

A chaperone enhances blood α-glucosidase activity in Pompe disease patients treated with enzyme replacement therapy.

A. Pichiecchio, L. Morandi, G. Andria, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.